Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide drives fat loss, not targeted muscle breakdown — but in practice, rapid weight loss from any cause can reduce muscle mass alongside fat. In clinical trials, the majority of weight lost on semaglutide came from fat tissue, though the proportion of lean mass lost was higher than in slower, diet-only approaches. That nuance matters, and it shapes how clinicians think about protecting muscle while on treatment. Semaglutide is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a reasonable thing to wonder. The scales have moved quickly, your clothes fit differently, and somewhere in the back of your mind a question has formed: is this fat coming off, or am I losing muscle too? A question our prescribers hear most weeks, and it deserves a straight answer.
Semaglutide, sold in the UK as Wegovy, works by activating the GLP-1 receptor. It reduces appetite, slows how quickly the stomach empties, and makes you feel full sooner. The result is a sustained calorie deficit, and it is that deficit, rather than any direct action on muscle tissue, that drives weight loss. Semaglutide does not seek out fat stores and ignite them, nor does it specifically break down muscle. What it does is make it much easier to eat less, consistently, over months. For a more detailed look at what semaglutide actually does to fat stores specifically, the semaglutide and fat burning page covers that question in full.
The mechanism matters here. A medicine that suppresses appetite creates the same physiological situation as a strict diet: the body draws on stored energy. How much of that comes from fat versus lean tissue depends on several factors, how fast you are losing weight, how much protein you eat, and how active you remain.
The STEP 1 trial, published in the New England Journal of Medicine, found that adults with obesity lost around 15% of their body weight over 68 weeks on semaglutide 2.4mg. Body composition analysis from the programme confirmed that most of this weight came from fat mass. Participants lost visceral fat (the metabolically active fat stored around the abdominal organs) alongside subcutaneous fat. If you are curious specifically about abdominal fat, the evidence around semaglutide and belly fat is worth reading alongside this page.
The harder truth is that lean mass did fall too. In the STEP trials, roughly 10–15% of total weight lost was lean mass, which is broadly in line with what happens during diet-induced weight loss generally. Some researchers have argued the proportion is slightly higher during GLP-1 treatment than during very slow calorie restriction, though this remains an active area of research. The NHS semaglutide medicines page notes that treatment should be combined with a reduced-calorie diet and increased physical activity, precisely because lifestyle factors influence what the body preferentially burns.
The practical upshot: semaglutide does not burn muscle in any deliberate sense, but losing weight quickly without adequate protein or resistance training means some muscle loss is likely, as it would be with any other effective weight-loss approach.
The two most evidence-supported ways to preserve lean mass during weight loss are also the most straightforward: eat enough protein and keep your muscles under load. Neither of these is new science (both were true before GLP-1 medicines existed) but they take on added importance when appetite is significantly suppressed.
When semaglutide works well, people eat considerably less. That's the goal. The risk is that overall food volume falls so sharply that protein intake drops below what muscles need to maintain themselves. A conscious effort to include protein-rich foods at each meal (eggs, fish, lean meat, legumes, dairy or fortified plant alternatives) helps protect lean mass even when total calories are low. If you are exploring different formulations of this medicine, our page on liquid semaglutide explains how that version works and who it might suit.
Resistance exercise matters for similar reasons. Muscles that are regularly loaded send a signal to preserve themselves; muscles that go unused during a calorie deficit are more readily broken down for energy. You do not need a gym membership or a formal programme, two to three sessions a week of bodyweight exercises, resistance bands, or weights can make a meaningful difference to the lean-mass picture over the months treatment runs. The question of whether muscle gain is possible on semaglutide is more complex, but protecting what you have is achievable for most people.
One practical note: appetite suppression can fluctuate during dose increases and, for some people, around the weekly injection day. Planning higher-protein meals earlier in the week (rather than leaving them to chance when hunger is lowest) is a small adjustment that can add up over time.
The body composition question is genuinely important, and it is one your prescriber can discuss with you. Treatment is not just about the number on the scales; it is about what kind of weight comes off and how well your overall health holds up across the months of treatment. How Wegovy helps with fat loss and whether it suits your situation are distinct questions, one is about mechanism, the other is clinical and individual.
If you are considering treatment, or already on it and thinking about muscle preservation, the free consultation with our prescribing team is the right place to raise this. A clinician (a real one, reviewing your case the same day) is better placed than any general article to weigh your diet, your activity level, your current health, and what a sensible treatment plan looks like for you specifically. That is what the consultation is for.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.